Publication | Closed Access
Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis
41
Citations
18
References
2017
Year
Hematological MalignancyMedicineMulticenter Phase 2HematologyPharmacologyPharmacotherapyCombination TherapyOncologyMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1